| |
|
|
| Name: |
TCG Crossover Management LLC |
| City: |
PALO ALTO |
| State: |
CA |
| Zip: |
94301 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
21 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
INBX |
Inhibrx, Inc. |
2 |
- |
$0.00 |
$66,515,000 |
1,750,387 |
7.38% |
34,395,000 |
0 |
4.642 |
N/A |
|
|
ICVX |
Icosavax, Inc. |
3 |
- |
$0.00 |
$58,370,000 |
3,703,704 |
6.47% |
29,666,000 |
0 |
9.403 |
N/A |
|
|
ANTX |
An2 Therapeutics Ord Shs |
4 |
- |
$2.27 |
$54,877,000 |
2,678,209 |
6.09% |
11,811,000 |
0 |
13.798 |
N/A |
|
|
RYZB |
Rayzebio, Inc. |
5 |
- |
$62.49 |
$54,082,000 |
869,908 |
6% |
34,770,000 |
0 |
1.431 |
N/A |
|
|
AVTE |
Aerovate Therapeutics, Inc. |
6 |
- |
$0.00 |
$49,815,000 |
2,201,274 |
5.52% |
19,944,000 |
0 |
8.304 |
N/A |
|
|
GERN |
Geron Corporation |
7 |
- |
$3.90 |
$49,323,000 |
23,375,839 |
5.47% |
-234,000 |
0 |
6.832 |
Drug Manufacturers - ... |
|
|
SVRA |
Savara Inc |
8 |
- |
$4.72 |
$47,000,000 |
10,000,000 |
5.21% |
9,200,000 |
0 |
8.783 |
Biotechnology |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
10 |
- |
$217.17 |
$41,629,000 |
179,917 |
4.62% |
15,354,000 |
0 |
1.085 |
Diagnostic Substances |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
11 |
- |
$12.07 |
$41,595,000 |
3,395,495 |
4.61% |
8,896,000 |
0 |
10.057 |
N/A |
|
|
SLN |
Silence Therapeutics Adr Re... |
12 |
- |
$0.00 |
$36,562,000 |
2,104,875 |
4.05% |
15,892,000 |
0 |
7.061 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
13 |
- |
$0.00 |
$33,758,000 |
3,858,000 |
3.74% |
5,209,000 |
0 |
11.083 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
14 |
- |
$7.47 |
$33,111,000 |
5,631,042 |
3.67% |
-21,792,000 |
0 |
7.121 |
N/A |
|
|
TYRA |
Tyra Biosciences, Inc. |
15 |
- |
$0.00 |
$27,549,000 |
1,989,103 |
3.06% |
159,000 |
0 |
4.82 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
17 |
- |
$0.00 |
$23,143,000 |
1,142,857 |
2.57% |
2,834,000 |
0 |
4.285 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
18 |
- |
$28.75 |
$21,947,000 |
1,650,150 |
2.43% |
7,162,000 |
0 |
2.894 |
N/A |
|
|
KURA |
Kura Oncology Inc |
19 |
- |
$22.98 |
$20,472,000 |
1,423,642 |
2.27% |
7,488,000 |
0 |
1.869 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
20 |
- |
$0.00 |
$16,245,000 |
2,040,816 |
1.8% |
3,041,000 |
0 |
2.335 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
22 |
- |
$0.00 |
$11,050,000 |
486,795 |
1.23% |
3,641,000 |
0 |
1.882 |
N/A |
|
|
TRDA |
Entrada Therapeutics, Inc. |
23 |
- |
$0.00 |
$8,827,000 |
584,955 |
0.98% |
-415,000 |
0 |
1.874 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
25 |
- |
$0.00 |
$7,213,000 |
1,276,574 |
0.8% |
4,839,000 |
0 |
2.967 |
N/A |
|
|
VTYX |
Ventyx Biosciences, Inc. |
27 |
- |
$4.98 |
$2,015,000 |
815,724 |
0.22% |
-26,315,000 |
0 |
1.622 |
N/A |
|
